Banner
  • Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Mourning a history maker; waiting for emergency help; LSD as medicine – Morning Medical Update

News
Article

The top news stories in medicine today.

physician holding morning coffee: © batuhan toker - stock.adobe.com

© batuhan toker - stock.adobe.com

Losing a medical history maker

The first patient to receive a genetically modified pig kidney transplant has died, according to the Associated Press. Richard “Rick” Slayman, 62, of Weymouth, Massachusetts, appeared in good health after the operation and there was no indication he died because of the transplant.

Emergency department boarding

During the COVID-19 pandemic, emergency department conditions were bad for long wait times, risk of deteriorating health, and overworked staff. Now they are worse for older patients waiting – sometimes without food, bathroom breaks, or painkillers – to be admitted to hospitals. USA Today has this report from KFF Health News.

Rethinking LSD

It’s clear the regulatory agencies under President Joe Biden are moving to reclassify marijuana. Is it time to set aside prior beliefs and rethink the medicinal use of lysergide d-tartrate program (MM-120), or LSD, for generalized anxiety disorder? Here’s why one physician thinks it is time to revisit LSD as a treatment.

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice
Monica Verduzco-Gutierrez, MD, FAAPMR, gives expert advice
Monica Verduzco-Gutierrez, MD, FAAPMR, gives expert advice
Monica Verduzco-Gutierrez, MD, FAAPMR, gives expert advice
Monica Verduzco-Gutierrez, MD, FAAPMR, gives expert advice